Stent Related Symptoms Defined by Ureteral Stent Symptom Questionnaire in Patients With Image-Inf… (NCT07580963) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Stent Related Symptoms Defined by Ureteral Stent Symptom Questionnaire in Patients With Image-Informed Ureteral Stent Lengths
United States128 participantsStarted 2026-05
Plain-language summary
Placement of a ureteral stent at the end of ureteroscopy is commonly performed in endourology. The purpose of this study is to determine whether ureteral stents whose lengths are calibrated to a participant's specific ureteral length based on imaging are better tolerated than one-size-fits-all variable length ureteral stents. The investigators hypothesize that ureteral stent lengths calibrated to the ureteral length of each participant will be better tolerated.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Male or female age 18-80 years
. Urolithiasis requiring ureteroscopic management with ureteral stent placement
. CT scan showing evidence of upper tract urolithiasis
. Negative pre-operative urine culture
. No symptoms of urinary tract infection
Exclusion criteria
. Known urinary tract anatomical abnormality, reconstructed urinary system, or congenital anomaly
. Ureteral stent inserted within the last 31 days
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Differences in scores as measured by the USSQ between the two treatment arms.
Timeframe: 5 hours post-surgery
2
Differences in scores as measured by the USSQ between the two treatment arms.
Timeframe: Post-intervention on Day 3
3
Differences in scores as measured by the USSQ between the two treatment arms.
Timeframe: Post-intervention on Day 7
Trial details
NCT IDNCT07580963
SponsorWeill Medical College of Cornell University